BAYTACARE PHARMACEUTICAL CO., LTD. Inactive Instrument
Baytacare Pharmaceutical Co., Ltd. Stock
Equities
8197
CNE100000155
Pharmaceuticals
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Nan Zhu
DFI | Director of Finance/CFO | 50 | 16-06-30 |
Bing Yan Cui
CMP | Compliance Officer | 51 | 16-01-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tian Xiang Zhu
BRD | Director/Board Member | 51 | 19-04-23 |
Bing Yan Cui
CMP | Compliance Officer | 51 | 16-01-09 |
Ai Qun Guo
BRD | Director/Board Member | 53 | 16-01-09 |
Baytacare Pharmaceutical Co., Ltd., formerly Northeast Tiger Pharmaceutical Co., Ltd., is principally engaged in the sales of pharmaceutical products. The Company mainly operates through two business segments. The Medicines Business segment is engaged in the development, manufacture and sales of medicines. The Chinese Herbs Business segment is engaged in the planting, cultivation and sales of Chinese herbs. The Company mainly conducts its businesses in Mainland China. The Company is also engaged in the investment holding business through its subsidiaries in the People's Republic of China (the PRC). Its principal subsidiary includes Antao County Northeast Tiger Xinxing New Products Co., Limited.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +37.37% | 6.02B | |
| -15.69% | 4.49B | |
| -12.46% | 3.06B | |
| -0.12% | 3.04B | |
| +0.47% | 2.61B | |
| +36.06% | 1.81B | |
| +0.84% | 1.66B | |
| -10.60% | 1.63B | |
| -12.03% | 1.55B |
